Form 8-K RxSight, Inc. For: Jun 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/19/2026
- Wall St ends lower for the day and week as chip selloff broadens
- Netflix earnings forecast disappoints Wall Street, shares tumble
- HSBC upgrades Apple to Buy, sees "strong cycle ahead"
- Kimi K3 AI breakthrough: What Wall Street analysts say about China’s OpenAI threat
- Why the Fed may still need to hike rates
- Assassin's Creed Black Flag Resynced sells 3M copies in a week
- Magnitude 7.4 earthquake strikes coast of Chiapas, Mexico; Tsunami waves are possible
- Magnitude 7.4 earthquake strikes Puerto Madero, Mexico, USGS says
- Medifast launches Trilivy, replacing its Optavia brand
- Adobe has received a takeover approach by a Big Tech company - Betaville
RxSight Inc. (RXST) PT Lowered to $6.50 at BofA Securities
July 7, 2026 12:24 PM EDTBofA Securities analyst Craig Bijou lowered the price target on RxSight Inc. (NASDAQ: RXST) to $6.50 (from $8.00) while maintaining a Underperform rating.
The analyst comments "RXST pre-Ad preliminary Q2 sales of $27m vs Street of $32m and lowered 2026 guidance by $13m at... More
